Related Experiment Video
Updated: Oct 2, 2025

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype:
Ana Canseco-Alba1, Branden Sanabria2, Mariam Hammouda2
1Dirección de Investigación, Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", Mexico City, Mexico.
Abstract:
DAT-Cnr2 mice are conditional knockout (cKO) animals that do not express cannabinoid CB2 receptors (CB2R), in midbrain dopamine neurons. The hyperactivity phenotype of DAT-Cnr2 cKO mice were paradoxically reduced by low dose of amphetamine. Here, we report on the locomotor activity analysis in male and female adolescent (PND 30 ± 2) mice in basal conditions and in response to different doses of amphetamine, using the Open Field (OF), Elevated Plus-Maze (EPM) tests and the Novel Object Recognition (NOR) task as a putative model of attention deficit hyperactivity disorder (ADHD). Results showed that both male and female adolescent DAT-Cnr2 mice displayed significant increases in distance traveled in the OF test compared with WT mice. However, 2 mg/kg dose of amphetamine reduced the distance traveled by the DAT-Cnr2 but was increased in the WT mice. In the EPM test of anxiety-like behavioral responses, DAT-Cnr2 spent more time in the open arms of the maze than the WT mice, suggesting a reduction in anxiety-like response. DAT-Cnr2 mice showed significant increase in the number of unprotected head dips in the maze test and in the cliff avoidance reaction (CAR) test demonstrating impulsivity and risky behavior. DAT-Cnr2 mice also exhibited deficient response in the delay decision making (DDM), with impulsive choice. Both DAT-Cnr2 and WT were able to recognize the new object in the NOR task, but the exploration by the DAT-Cnr2 was less than that of the WT mice. Following the administration of 2 mg/kg of amphetamine, the similarities and differential performances of the DAT-Cnr2 and WT mice in the EPM test and NOR task was probably due to increase in attention. Microglia activation detected by Cd11b immunolabelling was enhanced in the hippocampus in DAT-Cnr2 cKO than in WT mice, implicating neuro-immune modulatory effects of CB2R. The results demonstrates that DAT-Cnr2 cKO mice with cell-type specific deletion of CB2R in midbrain dopaminergic neurons may represent a possible model for studying the neurobiological basis of ADHD.
Insights
Adolescent mice lacking cannabinoid CB2 receptors (CB2R) in dopamine neurons exhibit hyperactivity and impulsivity, suggesting a potential model for attention deficit hyperactivity disorder (ADHD). Amphetamine paradoxically reduced hyperactivity in these DAT-Cnr2 mice.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Cannabinoid CB2 receptors (CB2R) play a role in the central nervous system.
- Dopamine neurons are implicated in attention and impulse control.
- Understanding CB2R function in dopaminergic pathways is crucial for neurological disorders.
Purpose of the Study:
- To investigate the behavioral phenotype of DAT-Cnr2 conditional knockout (cKO) mice lacking CB2R in midbrain dopamine neurons.
- To assess the effects of amphetamine on locomotor activity and behavior in these mice.
- To explore the potential of DAT-Cnr2 cKO mice as a model for attention deficit hyperactivity disorder (ADHD).
Main Methods:
- Locomotor activity analysis using Open Field (OF) and Elevated Plus-Maze (EPM) tests.
- Novel Object Recognition (NOR) task to assess recognition memory.
- Assessment of impulsivity and decision-making using Cliff Avoidance Reaction (CAR) and Delay Decision Making (DDM) tasks.
- Immunohistochemical analysis of microglia activation (Cd11b).
Main Results:
- DAT-Cnr2 cKO mice showed increased locomotor activity and reduced anxiety-like behavior compared to Wild Type (WT) mice.
- Amphetamine (2 mg/kg) paradoxically reduced locomotor activity in DAT-Cnr2 cKO mice while increasing it in WT mice.
- DAT-Cnr2 cKO mice displayed increased impulsivity and risky behavior, with impaired delay-based decision-making.
- Enhanced microglia activation was observed in the hippocampus of DAT-Cnr2 cKO mice, suggesting neuro-immune involvement.
Conclusions:
- Cell-type specific deletion of CB2R in midbrain dopaminergic neurons leads to hyperactivity, impulsivity, and altered amphetamine response.
- DAT-Cnr2 cKO mice present a valuable model for studying the neurobiological underpinnings of ADHD.
- CB2R signaling in dopaminergic neurons may modulate neuro-immune responses relevant to ADHD pathophysiology.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

